Literature DB >> 19723153

CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease.

Kikkeri N Naresh, Pritesh Trivedi, Donna Horncastle, Mark Bower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19723153     DOI： 10.1111/j.1365-2559.2009.03344.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  8 in total

1.  Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Victoria Wang; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Stefania Pittaluga; Deirdre O'Mahony; Denise Whitby; Giovanna Tosato; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

2.  Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Denise Whitby; Victoria Wang; Stefania Pittaluga; Deirdre O'Mahony; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

Review 3.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

Review 4.  Biologic Agents in the Treatment of Multicentric Castleman Disease.

Authors:  Konstantinos Kapriniotis; Savvas Lampridis; Sofoklis Mitsos; Davide Patrini; David R Lawrence; Nikolaos Panagiotopoulos
Journal:  Turk Thorac J       Date:  2018-10-01

5.  Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.

Authors:  Dirk P Dittmer; Kristy L Richards; Blossom Damania
Journal:  Front Microbiol       Date:  2012-04-18       Impact factor: 5.640

6.  Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Duosha Hu; Robert Yarchoan
Journal:  Front Microbiol       Date:  2012-03-02       Impact factor: 5.640

Review 7.  Molecular Virology of KSHV in the Lymphocyte Compartment-Insights From Patient Samples and De Novo Infection Models.

Authors:  Farizeh Aalam; Jennifer Totonchy
Journal:  Front Cell Infect Microbiol       Date:  2020-12-04       Impact factor: 5.293

8.  Castleman's disease.

Authors:  Himanshu Srivastava; Dulganti Santosh Reddy; Shreyas N Shah; Vandana Shah
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.